Form 4: Blend Labs Executive Brian Kneafsey Reports Stock Transactions
SEC Form 4 Filing
Brian Kneafsey, Head of Revenue at Blend Labs, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On February 20, 2025, Brian Kneafsey, Head of Revenue at Blend Labs, reported transactions involving Class A Common Stock.
- 75,000 Restricted Stock Units (RSUs) vested, each representing a contingent right to receive one share of BLND Class A Common Stock.
- Shares were withheld to cover tax obligations in connection with the vesting of RSUs, totaling 28,325 shares at a price of $3.99.
- Following these transactions, Kneafsey directly owns 823,434 shares of Class A Common Stock.
- Kneafsey also directly owns 300,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing detailing stock transactions. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is a standard practice for publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of earliest transaction: Vesting of Restricted Stock Units and tax withholding. |
| 02/21/2025 | Date of signature by Attorney-in-fact. |
Keywords
Blend Labs, BLND, Form 4, Brian Kneafsey, Restricted Stock Units, RSU, Class A Common Stock, Insider Trading, Beneficial Ownership, Head of Revenue
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.